Scarica l'app Stockscreener
25.36
3.56%
0.8215
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$24.54
Aprire:
$24.94
Volume 24 ore:
651.24K
Relative Volume:
0.86
Capitalizzazione di mercato:
$1.17B
Reddito:
$595.19M
Utile/perdita netta:
$28.96M
Rapporto P/E:
-20.00
EPS:
-1.2679
Flusso di cassa netto:
$30.93M
1 W Prestazione:
-8.85%
1M Prestazione:
-10.80%
6M Prestazione:
-13.91%
1 anno Prestazione:
-38.12%
Intervallo 1D:
$24.60
$25.91
Intervallo di 1 settimana:
$23.77
$28.12
Portata 52W:
$23.77
$45.26
Azenta Inc Stock (AZTA) Company Profile
Nome
Azenta Inc
Settore
Industria
Telefono
(978) 262-2400
Indirizzo
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
25.39 | 1.13B | 595.19M | 28.96M | 30.93M | -1.2679 |
|
ISRG
Intuitive Surgical Inc
|
502.13 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.26 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.01 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.90 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.16 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Reiterato | Needham | Buy |
| 2025-10-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Ripresa | Stephens | Equal-Weight |
| 2024-12-18 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Iniziato | Jefferies | Hold |
| 2024-02-01 | Reiterato | B. Riley Securities | Buy |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2023-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Ripresa | B. Riley Securities | Buy |
| 2022-03-21 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Azenta Inc Borsa (AZTA) Ultime notizie
Azenta Acquires UK Biocentre to Expand European Biorepository - TipRanks
Azenta acquires UK Biocentre for £20.5 million - Investing.com India
Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities - marketscreener.com
Azenta to Acquire UK Biocentre for GBP 20.5 Million to Build European SRS Hub - TradingView
Azenta (AZTA) acquires UK Biocentre in GBP 20.5m European hub deal - Stock Titan
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - PR Newswire
Vanguard Group Inc. Lowers Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (AZTA) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Has $9.88 Million Position in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Azenta stock hits 52-week low at 23.88 USD By Investing.com - Investing.com Canada
Azenta at 47th Annual Raymond James Conference: Strategic Turnaround Insights - Investing.com
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of "Hold" by Brokerages - MarketBeat
3 Reasons AZTA is Risky and 1 Stock to Buy Instead - Finviz
AZTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Rate Hike: Can Azenta Inc keep up with sector leaders2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta schedules Raymond James investor talk with 4 p.m. webcast - Stock Titan
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - Finviz
Rate Cut: Will Azenta Inc benefit from rising consumer demand2025 Market Trends & Accurate Technical Buy Alerts - baoquankhu1.vn
Jupiter Asset Management Ltd. Purchases 77,869 Shares of Azenta, Inc. $AZTA - MarketBeat
Will Azenta Inc. stock continue upward momentum2025 Sector Review & Weekly High Return Opportunities - mfd.ru
Decliners Report: Will Azenta Inc benefit from sector rotationQuarterly Risk Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Microgravity Trial Advances Space Lab Research - Technology Networks
Can Azenta Inc. grow without external fundingJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
KeyBanc reiterates Sector Weight on Azenta stock after conference By Investing.com - Investing.com South Africa
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (AZTA) Stock Analysis: Is A 35.10% Potential Upside Worth Considering? - DirectorsTalk Interviews
KeyBanc reiterates Sector Weight on Azenta stock after conference - Investing.com
A Look At Azenta (AZTA) Valuation After Its Transitional Earnings Update - Yahoo Finance
Azenta’s Space Research Partnership Sparks Questions On Valuation And Growth Potential - Yahoo Finance
Azenta to Participate in the Stephens Annual Investment Conferen - GuruFocus
Why Azenta Inc. stock appeals to analystsJuly 2025 Setups & Daily Profit Focused Stock Screening - mfd.ru
Can Azenta Inc. stock surprise with earnings upsideJuly 2025 Decliners & Low Risk Growth Stock Ideas - mfd.ru
Caprock Group LLC Invests $1.64 Million in Azenta, Inc. $AZTA - MarketBeat
AlphaQuest LLC Decreases Stake in Azenta, Inc. $AZTA - MarketBeat
Can Azenta Inc. stock deliver surprise earnings beat2025 Trading Volume Trends & Low Volatility Stock Recommendations - mfd.ru
Is Azenta Inc. stock trending bullishQuarterly Profit Report & Free Community Consensus Stock Picks - mfd.ru
Azenta’s Space Trials Put Sample Tools And Valuation In New Focus - Sahm
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know - Yahoo Finance
Azenta (AZTA) price target increased by 15.88% to 39.34 - MSN
Azenta announces $250 million share repurchase program - MSN
Can Azenta Inc. keep up with sector leaders2025 Support & Resistance & Daily Profit Maximizing Tips - mfd.ru
Will Mesa Laboratories Inc benefit from sector rotationJuly 2025 Opening Moves & Community Verified Trade Alerts - baoquankhu1.vn
Is Azenta Inc. benefiting from innovation trendsQuarterly Growth Report & Free Daily Entry Point Trade Alerts - mfd.ru
Will Azenta Inc. benefit from rising consumer demandBond Market & Daily Stock Trend Watchlist - mfd.ru
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica - GlobeNewswire Inc.
The Top 5 Analyst Questions From Azenta's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Azenta’s Q4 Earnings Call - Barchart.com
Azenta Inc Azioni (AZTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Azenta Inc Azioni (AZTA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
0.98%
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):